Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information for the purposes of Article 7 under the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.
BWA Group plc
("BWA" or "the Company" or "the Group")
Grant of Executive Options
BWA Group plc [AQSE: BWAP], which has seven mineral exploration licences in Canada and Cameroon at various stages of development from grass roots to advanced exploration, and is quoted on London's AQSE Growth Market (formerly NEX), announces additional options have been granted to Directors of the Company on 26th June 2020.
Each of Messrs Battersby, Butterfield and Borrelli have existing options to subscribe for 5,871,262 ordinary shares of 0.5p each in the Company ("Ordinary Shares") at a price of 0.65p per share.
New Options will be granted to the four Directors, now including James Hogg appointed on 1st June 2020, totalling 21,386,214 at a price of 0.5 pence per share and the issuance of new options as set out below.
Richard Battersby
James Butterfield
Alex Borrelli
James Hogg
Existing Share Options
5,871,262
5,871,262
5,871,262
Nil
New Share Options
6,128,738
6,128,738
6,128,738
3,000,000
Total Share Options
12,000,000
12,000,000
12,000,000
3,000,000
The Share Options set out above total 39,000,000 and represent approximately 13.1% of the Company's current issued share capital.
The Directors of the Company accept responsibility for the content of this announcement.
- Ends -
For further information, contact:
BWA Group PLC Richard Battersby Chairman
+44 (0)7836 2381721 enquiries@bwagroupplc.com
Allenby Capital Limited Corporate Adviser Nick Harriss/James Hornigold
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHFLMITMTATBFM
